Atlas Venture closes USD350m Fund XI
Atlas Venture, an early stage venture capital firm investing in groundbreaking biotech innovation, has closed ts eleventh fund, raising USD350 million in a highly oversubscribed fundraise. With Fund XI, Atlas Venture will continue to advance its mission of doing well by doing good, building biotech companies to deliver high-impact therapies